Induction of myelodysplasia by myeloid-derived suppressor cells-Reference-Cited by-同舟云学术

Induction of myelodysplasia by myeloid-derived suppressor cells

Published:2013-10-15 Issue:11 Volume:123 Page:4595-4611
ISSN:0021-9738
Container-title:Journal of Clinical Investigation
language:en
Short-container-title:J. Clin. Invest.

Author:

Chen Xianghong,Eksioglu Erika A.,Zhou Junmin,Zhang Ling,Djeu Julie,Fortenbery Nicole,Epling-Burnette Pearlie,Van Bijnen Sandra,Dolstra Harry,Cannon John,Youn Je-in,Donatelli Sarah S.,Qin Dahui,De Witte Theo,Tao Jianguo,Wang Huaquan,Cheng Pingyan,Gabrilovich Dmitry I.,List Alan,Wei Sheng

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Reference64 articles.

1. Biological Significance of Proliferation, Apoptosis, Cytokines, and Monocyte/Macrophage Cells in Bone Marrow Biopsies of 145 Patients With Myelodysplastic Syndrome

2. Inhibition of p38α MAPK disrupts the pathological loop of proinflammatory factor production in the myelodysplastic syndrome bone marrow microenvironment

3. Tumour necrosis factor-induced gene expression in human marrow stroma: clues to the pathophysiology of MDS?

4. Chronic Immune Stimulation Might Act As a Trigger for the Development of Acute Myeloid Leukemia or Myelodysplastic Syndromes

5. Demand-adapted regulation of early hematopoiesis in infection and inflammation

Cited by 263 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Myeloid-derived suppressor cells: Implication in myeloid malignancies and immunotherapy;Acta Histochemica;2024-10

2. Prototypical innate immune mechanism hijacked by leukemia-initiating mutant stem cells for selective advantage and immune evasion in Ptpn11-associated juvenile myelomonocytic leukemia;2024-08-02

3. Glioma-Associated Sialoglycans Drive the Immune Suppressive Phenotype and Function of Myeloid Cells;Pharmaceutics;2024-07-19

4. Increased myeloid‐derived suppressor cell activation in clonal cytopenia of undetermined significance and low‐risk myelodysplastic syndrome;British Journal of Haematology;2024-06-21

5. Targeting MCL1-driven anti-apoptotic pathways overcomes blast progression after hypomethylating agent failure in chronic myelomonocytic leukemia;Cell Reports Medicine;2024-06